ATE442858T1 - Nukleinsäureadjuvantien - Google Patents

Nukleinsäureadjuvantien

Info

Publication number
ATE442858T1
ATE442858T1 AT01274277T AT01274277T ATE442858T1 AT E442858 T1 ATE442858 T1 AT E442858T1 AT 01274277 T AT01274277 T AT 01274277T AT 01274277 T AT01274277 T AT 01274277T AT E442858 T1 ATE442858 T1 AT E442858T1
Authority
AT
Austria
Prior art keywords
nucleic acid
molecules
truncated
acid adjuvants
coding region
Prior art date
Application number
AT01274277T
Other languages
English (en)
Inventor
Joel Haynes
Joshua Arrington
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Application granted granted Critical
Publication of ATE442858T1 publication Critical patent/ATE442858T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01274277T 2000-11-27 2001-11-26 Nukleinsäureadjuvantien ATE442858T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72431500A 2000-11-27 2000-11-27
PCT/US2001/043151 WO2003004055A2 (en) 2000-11-27 2001-11-26 Nucleic acid adjuvants

Publications (1)

Publication Number Publication Date
ATE442858T1 true ATE442858T1 (de) 2009-10-15

Family

ID=24909936

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01274277T ATE442858T1 (de) 2000-11-27 2001-11-26 Nukleinsäureadjuvantien

Country Status (16)

Country Link
EP (1) EP1379273B1 (de)
JP (1) JP4221289B2 (de)
KR (1) KR20040045391A (de)
CN (1) CN1317034C (de)
AT (1) ATE442858T1 (de)
AU (1) AU2001297988B2 (de)
BR (1) BR0115646A (de)
CA (1) CA2429708A1 (de)
DE (1) DE60139959D1 (de)
DK (1) DK1379273T3 (de)
ES (1) ES2332261T3 (de)
IL (2) IL156041A0 (de)
MX (1) MXPA03004638A (de)
NZ (1) NZ526175A (de)
PT (1) PT1379273E (de)
WO (1) WO2003004055A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ546554A (en) 2003-10-10 2009-04-30 Powderject Vaccines Inc Nucleic acid constructs
ES2387850T3 (es) 2004-02-11 2012-10-02 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.R.L. Proteína de fusión al antígeno carcinoembrionario y sus usos
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
JP5311508B2 (ja) * 2008-05-07 2013-10-09 国立大学法人大阪大学 非共有結合型コラーゲン架橋剤
WO2012036746A1 (en) 2010-09-15 2012-03-22 Randall J Mrsny Systems and methods of delivery of bioactive agents using bacterial toxin-derived transport sequences
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
CN103060253A (zh) * 2013-01-24 2013-04-24 麻丽丹 霍乱弧菌ctxAB基因的质粒克隆菌株以及制备方法和应用
RU2723178C2 (ru) 2014-05-07 2020-06-09 ЭППЛАЙД МОЛЕКЬЮЛАР ТРАНСПОРТ ЭлЭлСи Слитые молекулы, происходящие от Cholix-токсина, для пероральной доставки биологически активных нагрузок
KR20210076881A (ko) 2018-03-08 2021-06-24 어플라이드 몰레큘라 트랜스포트 인크. 경구 전달용 독소-유래 전달 구조체
PL3650037T3 (pl) 2018-11-07 2022-06-06 Applied Molecular Transport Inc. Konstrukty dostarczające do transcytozy i powiązane z nimi sposoby
TW202120521A (zh) 2019-08-16 2021-06-01 美商應用分子運輸公司 組合物、配方及介白素生產及純化

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
GB9416663D0 (en) 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
JP3853360B2 (ja) 1994-10-24 2006-12-06 パウダージェクト リサーチ リミテッド 粒子供給装置
GB9426379D0 (en) 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
US6056960A (en) * 1995-06-07 2000-05-02 Kaslow; Harvey R. Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
US5980898A (en) * 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization

Also Published As

Publication number Publication date
EP1379273B1 (de) 2009-09-16
JP2004536107A (ja) 2004-12-02
DE60139959D1 (de) 2009-10-29
ES2332261T3 (es) 2010-02-01
AU2001297988B2 (en) 2006-10-26
WO2003004055A2 (en) 2003-01-16
CN1317034C (zh) 2007-05-23
EP1379273A2 (de) 2004-01-14
DK1379273T3 (da) 2009-11-09
IL156041A (en) 2010-05-17
CA2429708A1 (en) 2003-01-16
IL156041A0 (en) 2003-12-23
BR0115646A (pt) 2005-12-13
WO2003004055A3 (en) 2003-11-20
MXPA03004638A (es) 2004-04-20
NZ526175A (en) 2006-01-27
JP4221289B2 (ja) 2009-02-12
KR20040045391A (ko) 2004-06-01
PT1379273E (pt) 2009-11-27
CN1537013A (zh) 2004-10-13

Similar Documents

Publication Publication Date Title
ATE491471T1 (de) Adjuvantien für dns impstoffe basierend auf imidazochinoline
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
BR9906927A (pt) Proteìnas de neisseria meningitidis
AU4078599A (en) Expression vectors for stimulating an immune response and methods of using the same
ATE181572T1 (de) Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe
DK1185691T3 (da) Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf
DK1347055T3 (da) Forbindelser til immunbehandling og diagnose af tuberkulose
DK1187591T3 (da) IBD-associerede mikrobielle antigener og fremgangsmåder til at anvende samme
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
ATE442858T1 (de) Nukleinsäureadjuvantien
DK0726955T3 (da) Kimære proteiner, som omfatter Borreliapolypeptider, og anvendelser heraf
DE60144201D1 (de) Lawsonia intracellularis Impfstoff
DK1379550T3 (da) Et kimært protein omfattende non-toxisk pseudomonas exotoxin A og en type IV pilin sekvenser
DK0639224T3 (da) Varianter i lectindomænet af selectin
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
DK0914437T3 (da) Identificering og kloning af et mykobakterieantigen svarende til et heparinbindende hæmagglutinin
DK0811071T3 (da) Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner
DK1279677T3 (da) GD3-mimetiske peptider
DE69840326D1 (de) Steigerung der immunantwort unter verwendung von zielgerichteten molekülen
WO2000063385A3 (en) Nucleic acid immunization
MXPA03010527A (es) Composicion de vacuna.
WO2000047227A3 (en) Mycobacterium tuberculosis, immunization
ATE414905T1 (de) Diabetesmodell
WO2002046378A3 (en) Alternative pol k nucleotide and amino acid sequence and methods for using
WO2002077648A3 (en) Pathogenic and commensal vaccine antigens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1379273

Country of ref document: EP